Logo

Teva Receives US FDA Approval for Generic Version of Epipen Auto-Injector

Share this

Teva Receives US FDA Approval for Generic Version of Epipen Auto-Injector

Shots:

  • Teva’s EpiPen and EpiPen Jr (epinephrine) auto-injector will be used to treat allergic reaction including anaphylaxis in adults and pediatric patients weighing >33 pounds
  • The US FDA approval is prompted to lower cost along with safety and effectiveness for patients
  • EpiPen will be marketed in 0.3 mg and 0.15 mg doses

  / | Ref: US FDA | Image: Seeking alpha


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions